Shaheen Limbada

Shaheen Limbada is an accomplished professional with extensive experience in clinical operations and leadership roles within the pharmaceutical industry. Currently serving as the Chief Operating Officer at WEP Clinical since September 2023, Shaheen previously held the position of Executive Vice President of Global Clinical Operations at Veristat from October 2018 to August 2023. As the CEO and Co-founder of Topstone Research from August 2012 to October 2018, Shaheen demonstrated entrepreneurship and operational expertise. Prior roles include Head of Clinical Operations North America at LEO Pharma, where responsibilities included overseeing clinical trials and process improvements, and various leadership positions at Cetero Research and AstraZeneca. Shaheen holds an education from the University of Toronto.